- Home
- BCDA vs RKDA Comparison
BCDA vs RKDA Comparison
Compare BCDA & RKDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCDA
- RKDA
- Stock Information
- Founded
- BCDA N/A
- RKDA 2002
- Country
- BCDA United States
- RKDA United States
- Employees
- BCDA N/A
- RKDA N/A
- Industry
- BCDA Biotechnology: Pharmaceutical Preparations
- RKDA Agricultural Chemicals
- Sector
- BCDA Health Care
- RKDA Industrials
- Exchange
- BCDA Nasdaq
- RKDA Nasdaq
- Market Cap
- BCDA 7.9M
- RKDA 7.8M
- IPO Year
- BCDA N/A
- RKDA 2015
- Fundamental
- Price
- BCDA $2.05
- RKDA $5.87
- Analyst Decision
- BCDA Strong Buy
- RKDA Strong Buy
- Analyst Count
- BCDA 1
- RKDA 1
- Target Price
- BCDA $25.00
- RKDA $6.00
- AVG Volume (30 Days)
- BCDA 31.3K
- RKDA 3.7M
- Earning Date
- BCDA 11-13-2024
- RKDA 11-12-2024
- Dividend Yield
- BCDA N/A
- RKDA N/A
- EPS Growth
- BCDA N/A
- RKDA N/A
- EPS
- BCDA N/A
- RKDA N/A
- Revenue
- BCDA $71,000.00
- RKDA $5,482,000.00
- Revenue This Year
- BCDA N/A
- RKDA N/A
- Revenue Next Year
- BCDA N/A
- RKDA $25.44
- P/E Ratio
- BCDA N/A
- RKDA N/A
- Revenue Growth
- BCDA N/A
- RKDA 24.00
- 52 Week Low
- BCDA $1.84
- RKDA $1.85
- 52 Week High
- BCDA $10.80
- RKDA $10.31
- Technical
- Relative Strength Index (RSI)
- BCDA 42.16
- RKDA 68.01
- Support Level
- BCDA $2.00
- RKDA $5.06
- Resistance Level
- BCDA $2.14
- RKDA $6.44
- Average True Range (ATR)
- BCDA 0.16
- RKDA 0.90
- MACD
- BCDA -0.00
- RKDA 0.19
- Stochastic Oscillator
- BCDA 15.91
- RKDA 42.48
About BCDA BioCardia Inc.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
About RKDA Arcadia Biosciences Inc.
Arcadia Biosciences Inc is a producer and marketer of plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water and others.